Press Release
ATAI Life Sciences Partners with Neuronasal Inc. to Develop Novel Treatment for mild Traumatic Brain Injury (mTBI)
BERLIN and WEXFORD, Pa., Jan. 6, 2020 /PRNewswire/ -- ATAI Life Sciences AG ("ATAI" or the "Company") , a global biotech platform that envisions an end to mental illnesses, today announced that it has partnered with Neuronasal Inc., to develop a short-term treatment for mild Traumatic Brain Injury
January 6, 2020
Press Release
GABA Therapeutics and ATAI Life Sciences Partner to Develop a Novel GABA Modulator for the Treatment of Mood Disorders
NEWPORT BEACH, Calif. and BERLIN, Sept. 20, 2019 /PRNewswire/ -- Today, GABA Therapeutics , a biotech company focused on the treatment of mood disorders, and ATAI Life Sciences , a global biotech company builder working on paradigm shifting interventions for unmet needs in the mental health space,
September 20, 2019
Displaying 85 - 86 of 86